ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 6 of 2993 for:    "Osteoarthritis"

Feasibility of High Intensity Interval Training in Knee Osteoarthritis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03281668
Recruitment Status : Recruiting
First Posted : September 13, 2017
Last Update Posted : December 13, 2017
Sponsor:
Collaborators:
National Institutes of Health (NIH)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Information provided by (Responsible Party):
University of North Carolina, Chapel Hill

Brief Summary:
The focus of this pilot study is to evaluate the feasibility of utilizing an evidenced-based high intensity interval training program (HIIT) to improve physical function in patients with knee osteoarthritis (OA).

Condition or disease Intervention/treatment Phase
Knee Osteoarthritis Behavioral: High intensity interval training (HIIT) Not Applicable

Detailed Description:
All participants will be assigned to the single-arm of the study in which all participants will receive 12 weeks of HIIT, delivered twice per week. The primary outcome will examine the feasibility and acceptability of the 12 week HIIT program in patients with knee OA symptoms ranging from mild to severe. The investigators will determine adherence to and tolerability of HIIT, acceptability, and recruitment and retention rates during the 12 week program. Additional outcomes will include physical function, knee OA symptomatic burden (pain), static standing balance, isometric knee extensor and flexor strength, cardiorespiratory fitness, and body composition.

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 30 participants
Intervention Model: Single Group Assignment
Intervention Model Description: Single Group assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Feasibility of High Intensity Interval Training in Knee Osteoarthritis
Actual Study Start Date : November 1, 2017
Estimated Primary Completion Date : June 30, 2019
Estimated Study Completion Date : June 30, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Osteoarthritis

Arm Intervention/treatment
Experimental: Intervention
Intervention consists of High Intensity Interval Training (HIIT) session which is af 3-5 minute warm up, followed by 10 repetitions of 1 minute bouts at individualized training intensity with 1 minute rest periods.
Behavioral: High intensity interval training (HIIT)
Each training session for High Intensity Interval Training will consist of a 3-5 minute warm-up, followed by 10 repetitions of 1-minute bouts at individualized training intensity with 1-minute rest periods.




Primary Outcome Measures :
  1. Proportion enrolled [ Time Frame: baseline ]
    percent of potential participants screened for the study who are enrolled

  2. Proportion retained [ Time Frame: study completion (12 weeks) ]
    proportion of enrolled participants retained at the end of the study


Secondary Outcome Measures :
  1. Compliance [ Time Frame: 12 weeks ]
    average number of training sessions completed per week

  2. Adherence - sessions per week [ Time Frame: 12 weeks ]
    total number of training sessions completed per week

  3. Adherence - weeks of training [ Time Frame: 12 weeks ]
    total number of training weeks completed

  4. Change in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) total score from baseline to 12 weeks [ Time Frame: Baseline,12 weeks ]
    The WOMAC, a measure of lower extremity pain (5 items), stiffness (2 items), and function (17 items), will be used to measure overall symptomatic burden of knee OA. Each item is scored from 0-4 (none, slight, moderate, severe, and extreme). Items are added to calculate a total WOMAC score ranging from 0 (no problems) to 96 (extreme problems). A higher score means a worse outcome.

  5. Change in WOMAC pain subscale from baseline to 12 weeks [ Time Frame: Baseline,12 weeks ]
    The WOMAC pain subscale contains 5 items about knee pain. Each item is scored from 0-4 (none, slight, moderate, severe, and extreme). Items are added to calculate a WOMAC pain score ranging from 0 (no pain) to 20 (extreme pain). A higher score means more severe pain.

  6. Change in WOMAC function subscale from baseline to 12 weeks [ Time Frame: Baseline, 12 weeks ]
    The WOMAC function subscale contains 17 items about knee function during daily activities. Each item is scored from 0-4 (none, slight, moderate, severe, and extreme). Items are added to calculate a WOMAC pain score ranging from 0 (no problems with function) to 68 (extreme problems with function). A higher score means worse function.

  7. Change in 40m fast paced walk test [ Time Frame: Baseline, 12 weeks ]
    Measure of the ability to walk quickly over short distances. Participants walks at fast pace that is timed over 4 x 10m.

  8. Change in 30-second chair stand test [ Time Frame: Baseline, 12 weeks ]
    Number of chair stand repetitions completed in 30 seconds

  9. Change in Stair climb test [ Time Frame: Baseline, 12 weeks ]
    Time in seconds to ascend and descend a flight of stairs

  10. Change in Timed Up and Go [ Time Frame: Baseline, 12 weeks ]
    Time in seconds to rise from a chair, walk 3 m, turn, walk back to chair, and sit down

  11. Change in Feet Together Stand [ Time Frame: Baseline, 12 weeks ]
    Feet together stand for up to 10 seconds without assistive device

  12. Change in Semi-tandem stand [ Time Frame: Baseline, 12 weeks ]
    Heel of one foot placed to the side of the big toe of the other foot, for up to 10 seconds

  13. Change in Tandem stand [ Time Frame: Baseline, 12 weeks ]
    One foot in front of the other, heel touching toe, for up to 10 seconds

  14. Change in One Leg Stand [ Time Frame: Baseline, 12 weeks ]
    One leg stand for up to 30 seconds

  15. Change in Cardiorespiratory fitness [ Time Frame: Baseline, 12 weeks ]
    Measure by peak oxygen consumption (VO2peak),to identify fitness level and evaluate cardiovascular effects. Test will establish individual training intensity.

  16. Change in whole body fat mass [ Time Frame: Baseline, 12 weeks ]
    fat mass in kilograms, measured with dual energy x-ray absorptiometry (DXA)

  17. Change in lean body mass [ Time Frame: Baseline, 12 weeks ]
    lean body mass in kilograms, measured with DXA

  18. Change in visceral fat [ Time Frame: Baseline, 12 weeks ]
    visceral fat in kilograms, measured with DXA

  19. Change in Knee Strength [ Time Frame: Baseline, 12 weeks ]
    Humac isokinetic dynamometer to measure isokinetic power and isometric strength of knee flexors and extensors



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   40 Years to 75 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • between the ages of 40 and 75 years old
  • body mass index of 18.5-50 kg/m²
  • exhibits symptomatic knee OA, defined as a diagnosis of knee OA, as identified from University of North Carolina electronic medical records, and current knee symptoms in at least one knee, having a minimum score of 6 out of 20 on the Western Ontario and McMasters Universities Osteoarthritis Index (WOMAC) pain subscale.

Exclusion Criteria:

  • individuals diagnosed with a cardiovascular condition restricting exercise
  • individuals currently meeting Department of Health and Human Services Guidelines for physical activity (≥ 150 minutes per week
  • individuals currently doing HIIT
  • individuals currently participating in physical therapy for knee OA
  • individuals currently participating in another OA intervention study
  • received a corticosteroid or hyaluronic acid intra-articular injection in the knee during the previous 3 weeks or scheduled for during the intervention
  • diagnosis of gout in the knee
  • diagnosis of rheumatoid arthritis
  • diagnosis of fibromyalgia
  • other systemic rheumatic disease
  • severe dementia or other memory loss
  • active diagnosis of psychosis or uncontrolled substance abuse disorder
  • hospitalization for a stroke, heart attack, or heart failure, or had surgery for blocked arteries in the past 3 months
  • total joint replacement knee surgery, other knee surgery, meniscus tear, or anterior cruciate ligament (ACL) tear in the past 6 months
  • on a waiting list for total joint replacement
  • severely impaired hearing or speech
  • pregnant or planning to become pregnant while enrolled in the study
  • inability to speak English
  • serious or terminal illness as indicated by referral to hospice or palliative care
  • nursing home residence
  • inability to ride a stationary bike
  • any other health problems that would prohibit safe participation in the study
  • EKG results EKG suggesting the individual would not be able to safely participate in this study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03281668


Contacts
Contact: Yvonne Golightly, PT, Phd 919 966-0566 golight@email.unc.edu
Contact: Betsy S Hackney 919 966--0574 bshackne@email.unc.edu

Locations
United States, North Carolina
University of North Carolina Recruiting
Chapel Hill, North Carolina, United States, 27599
Contact: Yvonne Golightly, PhD    919-966-0566    golight@email.unc.edu   
Contact: Betsy Hackney, BA    9199660574    bshackne@email.unc.edu   
Sponsors and Collaborators
University of North Carolina, Chapel Hill
National Institutes of Health (NIH)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Investigators
Principal Investigator: Yvonne Golightly, PT, PhD University of North Carolina, Chapel Hill

Responsible Party: University of North Carolina, Chapel Hill
ClinicalTrials.gov Identifier: NCT03281668     History of Changes
Other Study ID Numbers: 16-2996
1R21HD088852-01A1 ( U.S. NIH Grant/Contract )
First Posted: September 13, 2017    Key Record Dates
Last Update Posted: December 13, 2017
Last Verified: December 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by University of North Carolina, Chapel Hill:
Knee osteoarthritis

Additional relevant MeSH terms:
Osteoarthritis
Osteoarthritis, Knee
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases